Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
Journal: The New England journal of medicine
Published: July 01, 2026
The seventh kidney cancer research summit: progress in accelerating cures.
Journal: The oncologist
Published: March 31, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2026
Pathologic Complete Response After Preoperative Ipilimumab and Nivolumab in an HLRCC Patient with Stage III Renal Cell Carcinoma.
Journal: Journal of kidney cancer and VHL
Published: January 15, 2026
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 09, 2026
Differential Tumor Response Patterns and Extent of Necrosis After Immunotherapy Combinations Predict Clinical Responses for Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: December 04, 2025
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy.
Journal: medRxiv : the preprint server for health sciences
Published: December 03, 2025
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 14, 2025
Stereotactic Ablative Radiation Therapy for Oligoprogressive Metastatic RCC: Predictors of Prolonged Benefit from Ongoing Systemic Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: September 17, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
Novel pembrolizumab-based treatments as first-line therapy in advanced clear-cell renal cell carcinoma: substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 07, 2025
Stereotactic Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer: Final Results of a Phase 2b Trial.
Journal: European urology oncology
Published: August 21, 2025
Last Updated: 09/26/2026